Data/hora: 25/06/2024 13:02:20

Biblioteca(s): 	Embrapa Instrumentação.	
Data corrente: 	10/03/2023	
Data da última atualização: 	10/03/2023	
Autoria: 	GUEDES, M. D. V.; MARQUES, M. S.; BERLITZ, S. J.; FACURE, M. H. M.; CORREA, D. S.; STEFFENS, C.; CONTRI, R. V.; KÜLKAMP-GUERRREIRO, I. C.	
Afiliação: 	DANIEL SOUZA CORREA, CNPDIA.	
Título: 	Lamivudine and Zidovudine-Loaded Nanostructures: Green Chemistry Preparation for Pediatric Oral Administration.	
Ano de publicação: 	2023	
Fonte/Imprenta: 	Nanomaterials, v. 13, 770, 2023.	
Páginas: 	1 - 18	
DOI: 	https://doi.org/10.3390/nano13040770	
Idioma: 	Inglês	
Conteúdo: 	Here, we report on the development of lipid-based nanostructures containing zidovudine (1 mg/mL) and lamivudine (0.5 mg/mL) for oral administration in the pediatric population, eliminating the use of organic solvents, which is in accordance with green chemistry principles. The formulations were obtained by ultrasonication using monoolein (MN) or phytantriol (PN), which presented narrow size distributions with similar mean particle sizes (~150 nm) determined by laser diffraction. The zeta potential and the pH values of the formulations were around &#8722;4.0 mV and 6.0, respectively. MN presented a slightly higher incorporation rate compared to PN. Nanoemulsions were obtained when using monoolein, while cubosomes were obtained when using phytantriol, as confirmed by Small-Angle X-ray Scattering. The formulations enabled drug release control and protection against acid degradation. The drug incorporation was effective and the analyses using an electronic tongue indicated a difference in palatability between the nanotechnological samples in comparison with the drug solutions. In conclusion, PN was considered to have the strongest potential as a novel oral formulation for pediatric HIV treatment	
Palavras-Chave: 	Cubosomes; Nanoemulsion.	
Categoria do assunto: 	--	
Registro original: 	Embrapa Instrumentação (CNPDIA)	
Exemplares: 	CNPDIA - (18206-1) - UPC - AP - DD - PROCI.23/21 -  - 2023/25 - DIS